EP Patent

EP4464320A1 — Pharmaceutical composition comprising neurokinin-1 antagonist prodrug compound

Assigned to Jiangsu Hengrui Pharmaceutical Co Ltd · Expires 2024-11-20 · 1y expired

What this patent protects

A pharmaceutical composition comprising a neurokinin-1 antagonist prodrug compound. A pharmaceutical composition comprising a compound of formula I and a stabilizer, and a preparation method therefor.

USPTO Abstract

A pharmaceutical composition comprising a neurokinin-1 antagonist prodrug compound. A pharmaceutical composition comprising a compound of formula I and a stabilizer, and a preparation method therefor.

Drugs covered by this patent

Patent Metadata

Patent number
EP4464320A1
Jurisdiction
EP
Classification
—
Expires
2024-11-20
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.